DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Mukka Proteins Limited — Commencement or postponement (Sub-para 1-Para B)

NSE 1 hr ago·9 Oct 2026, 10:24 am

Mukka Proteins

Mukka Proteins has informed the stock exchanges about a significant development regarding its operations. The company has stated that it is considering the commencement or postponement of a specific project, as outlined in a sub-paragraph of its Para B. This update signals that the company is actively evaluating its timeline and strategy for this initiative.

For investors, this news is important because it could impact the company's future production capacity and financial performance. The outcome of this evaluation will determine when the project will move forward, which in turn may influence the stock's short-term price movements. It is a key development that warrants close monitoring by shareholders.